- Stocks
- Healthcare
- NASDAQ: ABVC

Price (delayed)

$0.6941

Market cap

$8.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.66

Enterprise value

$10.29M

Abvc Biopharma's EPS has surged by 57% YoY and by 26% QoQ

The debt has plunged by 53% YoY

The gross margin has dropped by 152% year-on-year but it has surged by 97% since the previous quarter

The gross profit has dropped by 109% year-on-year but it has surged by 85% since the previous quarter

The revenue has dropped by 82% year-on-year

What are the main financial stats of ABVC

Market
Valuations
Earnings

Shares outstanding

12.42M

Market cap

$8.62M

Enterprise value

$10.29M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.91

Price to sales (P/S)

57.61

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

75.44

Revenue

$136,396

EBIT

-$8.04M

EBITDA

-$8.01M

Free cash flow

-$3.35M

Per share
Balance sheet
Liquidity

EPS

-$1.66

Free cash flow per share

-$0.3

Book value per share

$0.76

Revenue per share

$0.01

TBVPS

$1.29

Total assets

$14.63M

Total liabilities

$6.81M

Debt

$2.41M

Equity

$8.29M

Working capital

-$4.36M

Debt to equity

0.29

Current ratio

0.33

Quick ratio

0.32

Net debt/EBITDA

-0.21

Margins
Efficiency
Dividend

EBITDA margin

-5,875.8%

Gross margin

-24.1%

Net margin

-8,339%

Operating margin

-6,259.4%

Return on assets

-75.6%

Return on equity

-135.5%

Return on invested capital

-74.9%

Return on capital employed

-99.5%

Return on sales

-5,897.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Abvc Biopharma stock price performed over time

Intraday

0.57%

1 week

5.33%

1 month

-1.76%

1 year

-41.67%

YTD

-40.16%

QTD

-10.32%

How have Abvc Biopharma's revenue and profit performed over time

Revenue

$136,396

Gross profit

-$32,891

Operating income

-$8.54M

Net income

-$11.37M

Gross margin

-24.1%

Net margin

-8,339%

The gross margin has dropped by 152% year-on-year but it has surged by 97% since the previous quarter

The gross profit has dropped by 109% year-on-year but it has surged by 85% since the previous quarter

The operating margin has soared by 84% since the previous quarter

The net margin has soared by 83% from the previous quarter

What is Abvc Biopharma's growth rate over time

What is Abvc Biopharma stock price valuation

P/E

N/A

P/B

0.91

P/S

57.61

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

75.44

Abvc Biopharma's EPS has surged by 57% YoY and by 26% QoQ

The P/B is 17% less than the last 4 quarters average of 1.1

ABVC's equity is up by 6% since the previous quarter

The revenue has dropped by 82% year-on-year

The P/S is 62% lower than the last 4 quarters average of 151.5

How efficient is Abvc Biopharma business performance

Abvc Biopharma's return on sales has surged by 84% QoQ

The company's return on equity has surged by 72% YoY and by 33% QoQ

ABVC's ROIC is up by 49% YoY and by 17% QoQ

The ROA has grown by 40% year-on-year and by 18% since the previous quarter

What is ABVC's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ABVC.

How did Abvc Biopharma financials performed over time

ABVC's total assets is 115% greater than its total liabilities

ABVC's total assets has surged by 57% year-on-year

The total liabilities is down by 30% year-on-year and by 2.4% since the previous quarter

The debt is 71% less than the equity

The debt to equity has surged by 102% year-on-year but it has declined by 6% since the previous quarter

The debt has plunged by 53% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.